Sarzi-Puttini P, Torta R, Marinangeli F, Biasi G, Spath M, Buskila D, Gracely R H, Giamberardino M A, Bazzichi L, Cazzola M, Di Franco M, Stisi S, Salaffi F, Casale R, Leardini G, Gorla R, Marsico A, Carignola R, Altomonte L, Ceccherelli F, Cassisi G, Arioli G, Alciati A, Atzeni F
Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Reumatismo. 2008 Jul-Sep;60 Suppl 1:50-8. doi: 10.4081/reumatismo.2008.1s.50.
Pharmacological treatment has been gradually enriched by a variety of compounds; however, no single drug is capable of fully managing the constellation of fibromyalgia (FM) symptoms. Currently, it is not possible to draw definite conclusions concerning the best pharmacological approach to managing FM because results of randomized clinical trials present methodological limitations and therapeutic programs are too heterogeneous for adequate comparison. However, a variety of pharmacological treatments including antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDS), opioids, sedatives, muscle relaxants and antiepileptics have been used to treat FM with varying results. In this review, we will evaluate those pharmacological therapies that have produced the most significant clinical results in treating FM patients. The nature of FM suggests that an individualized, multimodal approach that includes both pharmacologic and nonpharmacologic therapies seems to be the most appropriate treatment strategy to date.
药物治疗已逐渐因各种化合物而丰富;然而,没有一种单一药物能够完全控制纤维肌痛(FM)的一系列症状。目前,关于治疗FM的最佳药物方法,无法得出明确结论,因为随机临床试验的结果存在方法学局限性,且治疗方案差异太大,无法进行充分比较。然而,包括抗抑郁药、非甾体抗炎药(NSAIDs)、阿片类药物、镇静剂、肌肉松弛剂和抗癫痫药在内的多种药物治疗已被用于治疗FM,结果各异。在本综述中,我们将评估那些在治疗FM患者方面产生最显著临床效果的药物疗法。FM的性质表明,包括药物和非药物疗法的个体化、多模式方法似乎是迄今为止最合适的治疗策略。